# Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

> **NCT04043819** · PHASE1 · UNKNOWN · sponsor: **Personalized Stem Cells, Inc.** · enrollment: 125 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** PSC-01

## Key facts

- **NCT ID:** NCT04043819
- **Lead sponsor:** Personalized Stem Cells, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-07
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04043819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04043819, "Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04043819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*